News
Archive
Novadip Biosciences SA announces first pediatric patient with congenital pseudoarthrosis of the tibia undergoes implantation with NVD-003, an autologous tissue regeneration product, in Phase 1b/2a US/EU clinical trial
Trellis Bioscience announces positive interim Phase 1 results for TRL1068, a novel native human monoclonal antibody which reduces bacterial biofilm burden in chronic prosthetic joint infections
Paragraf acquires Cardea Bio to extend graphene electronics leadership
VUV Analytics announces $20 million financing
ProterixBio announces commercial offering of Quantitative Soluble ST2 Assay
Picocom and Antevia Networks collaborate to provide new innovative 5G in-building solutions for enterprise private networks
Back To News

September 28, 2017
ProterixBio
Focused on the development of molecular assessments to improve the management of chronic diseases, with an initial focus on COPD.